Testosterone Replacement Therapy (TRT) in appropriate patients can lead to a reduced risk of heart attack and stroke, lower blood sugar, reduced belly fat, improved bone density, enhanced sexual function and overall vitality to name a few… But what about Cancer?

One of the most persistent and damaging medical myths that has led to the underutilization of TRT is that testosterone causes, or increases the risk of, prostate cancer. Despite the fact that there has never been a single study supporting this myth, and numerous studies over the last several years have debunked it, many physicians still have lingering doubts. These doubts have led to the withholding of TRT from countless patients who would benefit from it.

The most recent analysis, No Evidence of TRT Link to Prostate Cancer, not only shows no increased risk of prostate cancer with TRT, but also a 50% reduction in the risk of aggressive prostate cancer. And while the researchers emphasize that the results do not prove that TRT has a protective effect on the prostate, the data at least suggests that it does.

Dr. George Shapiro, a Cardiologist and Age Management Physician with Cenegenics Elite Heath in New York states, “Testosterone therapy shows no greater risk of Prostate Cancer than placebo. In fact, aggressive/high-grade Prostate Cancer is associated with low serum Testosterone levels.”

For Cenegenics patients, especially those on TRT, the results of this most recent study are not likely to be a surprise, as the evidence continues to confirm the safety and multiple health benefits of TRT in appropriate patients.

For more information on the Cenegenics Elite Health program comprised of a low glycemic diet, targeted exercise and hormone balancing, contact Dr. Julie McCallen at Cenegenics Denver.